Hart Health Strategies provides a comprehensive policy briefing on a weekly basis. This in-depth health policy briefing is sent out at the beginning of each week. The health policy briefing recaps the previous week and previews the week ahead. It alerts clients to upcoming congressional hearings, newly introduced bills, regulatory announcements, and implementation activity related to the Patient Protection and Affordable Care Act (PPACA) and other health laws.


Trump Speech on Drug Prices Scheduled for 'Near Future'

President Trump’s speech on prescription drug prices is set to take place in the near future, according to the latest reports. The speech was previously scheduled for April 26 but will now take place on a later date. The President is expected to speak about the proposals contained in his fiscal year 2019 budget to reduce the cost of prescription medication, such as capping Medicare out-of-pocket (OOP) drug costs and allowing several states to test Medicaid drug price negotiation. While no new policies are expected to be unveiled during the speech, his remarks will likely coincide with a request for information from the U.S. Department of Health and Human Services (HHS) on drug pricing policies. The Office of Management and Budget (OMB) began review of the HHS Strategy to Lower Drug Prices and Reduce Out-of-Pocket Costs on April 17. The notice, which is not proposed regulation, comes from the HHS Office of the Secretary, and is not ‘economically significant,’ meaning that the total cost to government or industry is less than $100 million.

December 31, 1969: | Page 1 Page 2 Page 3 Page 4 Page 5 Page 6



 -  2019

 +  2018